Section of Cardiology, Department of Experimental and Applied Sciences, University of Brescia, Brescia, Italy.
Eur J Clin Invest. 2012 Apr;42(4):376-83. doi: 10.1111/j.1365-2362.2011.02593.x. Epub 2011 Sep 9.
Diabetes is associated with increased cardiovascular mortality. The aim of our study was to determine the prognostic factors for mortality in patients with type 2 diabetes (T2DM) and coronary artery disease (CAD) who underwent coronary angiography and percutaneous coronary intervention.
Four hundred and forty-five consecutive T2DM patients with significant CAD (≥ 75% stenosis) were included in our analysis. All patients underwent standard clinical examination, laboratory tests and transthoracic echocardiography with measurement of the left ventricular ejection fraction. Severity of CAD at the coronary angiography was evaluated using the Gensini score. Clinical follow-up was completed at 1, 3 and 6 years.
During a mean follow-up of 73·3 ± 22·1 months, 109 patients died (24·5%). Significant determinants of an increased risk of death at multivariable analysis were age (p < 0·001), serum creatinine (p = 0·001), peripheral vascular disease (p = 0·002), serum glucose (p = 0·004), serum fibrinogen (p = 0·011) and history of heart failure (HF, p = 0·011). When all the variables were entered as categorical variables, with continuous variables split at their median value, only history of HF, estimated glomerular filtration rate, serum glucose, serum fibrinogen (all p < 0·0001) and beta-blocker therapy at discharge (p = 0·027) were selected.
Our study shows a relatively good prognosis of patients with T2DM. Comorbidities, namely HF and renal impairment, are main determinants of survival.
糖尿病与心血管死亡率增加有关。我们研究的目的是确定接受冠状动脉造影和经皮冠状动脉介入治疗的 2 型糖尿病(T2DM)和冠状动脉疾病(CAD)患者死亡的预后因素。
我们的分析纳入了 445 例连续的 T2DM 合并严重 CAD(≥75%狭窄)患者。所有患者均接受了标准的临床检查、实验室检查和经胸超声心动图检查,测量左心室射血分数。冠状动脉造影时 CAD 的严重程度采用 Gensini 评分评估。临床随访完成于 1、3 和 6 年。
在平均 73.3±22.1 个月的随访中,109 例患者死亡(24.5%)。多变量分析显示,年龄(p<0.001)、血清肌酐(p=0.001)、外周血管疾病(p=0.002)、血糖(p=0.004)、血清纤维蛋白原(p=0.011)和心力衰竭史(HF,p=0.011)是死亡风险增加的重要决定因素。当所有变量均作为分类变量输入,连续变量以中位数分割时,仅 HF 病史、估算肾小球滤过率、血糖、血清纤维蛋白原(均 p<0.0001)和出院时β受体阻滞剂治疗(p=0.027)被选择。
我们的研究显示 T2DM 患者的预后相对较好。合并症,即 HF 和肾功能损害,是生存的主要决定因素。